CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise pro ...
New Hyde Park, New York, United States
of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical str...
Phase 2
New York, New York, United States
with a type of radiation therapy called stereotactic body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung ...
Phase 2
New York, New York, United States and 8 other locations
Pembrolizumab in first line patients with squamous non-small cell lung cancer and non-squamous non-small cell lung cancer...
Phase 2
Long Island City, New York, United States and 23 other locations
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) exp....
Phase 2
New York, New York, United States and 9 other locations
This is a phase I clinical trial to determine the maximum tolerated dose (MTD) of KK-LC-1 TCR-T cells for the treatment of metastatic cancers...
Phase 1
New Brunswick, New Jersey, United States and 1 other location
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
New York, New York, United States and 17 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
New York, New York, United States and 90 other locations
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
White Plains, New York, United States and 32 other locations
the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...
Phase 1, Phase 2
New York, New York, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal